BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 4, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2011

View Archived Issues

Nicardipine shows promise in study in subjects with Peyronie's disease / News in Context

Read More

Immune surrogate response predicts clinical efficacy for TroVax

Read More

TPP Global Development and University of Aberdeen enter into drug development agreement

Read More

MP-29-02 associated with significant improvements in symptoms of allergic rhinitis

Read More

IMD-0354 exhibits proapoptotic effects in CLL cells in vitro by targeting NF-kappa-B

Read More

BMS-520 identified as a potent and selective S1P1 receptor agonist

Read More

Pfizer targets IRAK-4 for autoimmune diseases

Read More

Roche prepares novel compounds that inhibit beta-secretase for diabetes

Read More

New azacyclic HSL inhibitors claimed by Roche for diabetes and related disorders

Read More

Mallinckrodt reports novel method for monitoring leukemia

Read More

Novel dopamine D3 receptor ligands designed at Pierre Fabre

Read More

The University of Manchester presents novel kinase inhibitors

Read More

Yuma Therapeutics gets grant to develop new therapeutics for Alzheimer's disease

Read More

Vertex reports results from ongoing phase III ENVISION study in cystic fibrosis

Read More

Adeona Pharmaceuticals receives additional grant for ongoing multiple sclerosis trial

Read More

MediGene's Veregen for the treatment of genital warts approved in Spain

Read More

CryoLife to expand cardiac surgery portfolio with acquisition of Cardiogenesis

Read More

FDA grants 510(k) clearance to BD Diagnostics for fully automated HSV assays

Read More

Eisai and Minophagen complete Japanese license agreement for CTCL treatment bexarotene

Read More

Toyama Chemical submits application in Japan for influenza treatment T-705

Read More

Takeda and Dainippon Sumitomo Pharma enter exclusive Japanese license agreement for ceftaroline

Read More

Astellas and Pfizer submit supplemental NDA in Japan to expand approval for Celecox

Read More

Bavarian Nordic files application with Health Canada for smallpox vaccine candidate Imvamune

Read More

Bionomics reports encouraging results from phase Ib trials of antianxiety candidate BNC-210

Read More

Seikagaku withdraws PMA for additional indication of Supartz in U.S.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

    Small-molecule TREM2 agonist advances to treat Alzheimer’s

    BioWorld Science
    Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
  • Amyloid beta peptides on neurons

    Amlogenyx’s AM-805 reduces amyloid plaques in AD

    BioWorld Science
    The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Atai Therapeutics patents new 5-HT2 receptor agonists

    BioWorld Science
    Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing